The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Bioconjugation Market At The End Of The 2026–2030 Forecast Period?
The bioconjugation market has experienced rapid expansion in recent years. It is projected to grow from $6.12 billion in 2025 to $6.89 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.5%. The market’s historical development can be attributed to increased biologics research endeavors, the widening scope of antibody-based therapeutics, advancements in diagnostic assay creation, the rising popularity of protein labeling methods, and the accessibility of standardized conjugation kits.
The bioconjugation market is projected to experience substantial expansion over the next few years, with its size forecast to reach $11.12 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.7%. This expected growth during the forecast period is primarily attributed to the increasing development of targeted drug conjugates, rising investments in precision medicine research, the expansion of companion diagnostics, a growing utilization of conjugated biomolecules in imaging, and an increasing demand for scalable conjugation workflows. Significant trends anticipated in this period include the increasing adoption of site-specific conjugation techniques, a rising use of advanced linker chemistries, the growing demand for high-purity conjugation reagents, the expansion of automated conjugation platforms, and an enhanced focus on ensuring stability and reproducibility.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33039&type=smp
What Drivers Are Shaping The Future Growth Of The Bioconjugation Market?
The growing need for targeted therapeutics is anticipated to drive the expansion of the bioconjugation market in the foreseeable future. Targeted therapeutics are medical interventions specifically crafted to identify and address disease-causing cells or molecules, thereby boosting treatment efficacy and lessening harm to healthy tissues. This surge in targeted therapeutics stems from the escalating requirement for precision medicine, which facilitates more exact treatment strategies, leading to better patient outcomes and fewer negative side effects. Bioconjugation plays a supportive role for targeted therapeutics by allowing the accurate attachment of drugs to specific targeting molecules, which enhances their selective delivery to affected cells and boosts their therapeutic potency. For example, data from February 2024, provided by the West China Hospital, Sichuan University, a medical research institution in China dedicated to advancing targeted therapies, indicates that more than 47 new targeted therapeutics received approval from the U.S. Food and Drug Administration in 2023. These approvals represented approximately 85.5% of all new drug approvals, highlighting a growing focus on precision-targeted treatment options within the United States. Consequently, the rising demand for targeted therapeutics is propelling the expansion of the bioconjugation market.
What Segment Types Make Up The Bioconjugation Market?
The bioconjugation market covered in this report is segmented –
1) By Product And Service: Consumables; Instruments; Service
2) By Biomolecule Type: Antibodies; Proteins; Peptides; Oligonucleotides; Other Biomolecules
3) By Technique: Chemical Conjugation; Enzyme-Mediated Conjugation; Click Chemistry; Photoreactive Crosslinking; Other Techniques
4) By Application: Therapeutics; Research And Development; Diagnostics
5) By End Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CRO) And Contract Manufacturing Organizations (CMOs); Academic And Research Institutes; Hospitals, Clinical And Diagnostic Laboratories
Subsegments:
1) By Consumables: Reagents; Buffers; Linkers; Kits; Resins; Chromatography Materials; Protein Purification Materials
2) By Instruments: Chromatography Systems; Spectroscopy Systems; Electrophoresis Systems; Automated Conjugation Platforms; Imaging Systems; Bioreactors
3) By Service: Custom Conjugation Services; Antibody Modification Services; Protein Labeling Services; Contract Research Services; Analytical Testing Services; Purification Services
Which Market Trends Are Creating New Opportunities In The Bioconjugation Market?
Major enterprises operating within the bioconjugation market are concentrating on developing sophisticated platforms, such as site-specific conjugation methods, to improve the precision of drug delivery, enhance coupling stability, and minimize off-target toxicity. Site-specific conjugation methods refer to bioconjugation techniques that enable the controlled attachment of therapeutic molecules, including drugs or RNAi, to biomolecules like antibodies, peptides, or oligonucleotides, thereby ensuring consistent activity and safety. For instance, in August 2023, BOCSCI Inc., a US-based supplier of research chemicals and bioconjugation services, introduced the XDC bioconjugation platform, a next-generation solution intended to optimize the synthesis of bioconjugates. Employing advanced conjugation strategies, such as unnatural amino acid incorporation, engineered cysteine conjugation, enzyme-assisted ligation, and glycoconjugation generation, this platform facilitates the precise manufacturing of antibody-drug conjugates, siRNA conjugates, and other targeted drug delivery molecules, empowering researchers to design safer and more effective biopharmaceuticals.
Who Are The Key Players Driving Competition In The Bioconjugation Market?
Major companies operating in the bioconjugation market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza Group AG, Agilent Technologies Inc., Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Vector Laboratories Inc., Promega Corporation, LGC Biosearch Technologies Ltd., TriLink BioTechnologies LLC, Creative PEGWorks Inc., Lumiprobe Corporation, Biotium Inc., Jena Bioscience GmbH, Quanta BioDesign Ltd., Setareh Biotech Inc., Baseclick GmbH, Biosynth Carbosynth Ltd., Glen Research Inc., BroadPharm Inc., and Biorbyt Ltd.
Read the full bioconjugation market report here:
https://www.thebusinessresearchcompany.com/report/bioconjugation-market-report
Which Global Regions Are Shaping The Competitive Landscape Of The Bioconjugation Market?
North America was the largest region in the bioconjugation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioconjugation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Bioconjugation Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33039&type=smp
Browse Through More Reports Similar to the Global Bioconjugation Market 2026, By The Business Research Company
Biopreservation Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report
Biocomposites Market Report 2026
https://www.thebusinessresearchcompany.com/report/biocomposites-global-market-report
Biotech Ingredient Market Report 2026
https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model